Advertisement

Reactions Weekly

, Volume 1729, Issue 1, pp 199–199 | Cite as

Olaparib

Drug resistance: case report
Case report

Reference

  1. Ma Y, et al. Response to olaparib in metastatic castration-resistant prostate cancer with germline BRCA2 mutation: A case report 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 11 Medical and Health Sciences 1103 Clinical Sciences. BMC Medical Genetics 19: No. 1, 17 Oct 2018. Available from: URL: http://doi.org/10.1186/s12881-018-0703-9 - China

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations